SRY and disorder of sexual differentiation: Notably, CRISPR/Cas9 has been utilized to correct or epigenetically activate gene expression in vitro, such as SRY promoter demethylation in embryonic stem cells, and targeted disruption of SOX9 enhancers to model 46, XX testicular DSD in mice.